The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis - PubMed (original) (raw)
The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis
Akiko Ueno et al. Rheumatol Int. 2005 Jun.
Abstract
The inflamed synovial tissue of rheumatoid arthritis (RA) is characterized by an infiltration with Th1 cells that predominantly express the chemokine receptors CXCR3 and CCR5. In this study, we investigated the production of the CXCR3-agonistic chemokines CXCL9, CXCL10, and CXCL11 by synovial tissue cells and synovial fibroblast-cell lines (fourth or fifth passage) from RA patients. Concentrations of all CXCR3 ligands in synovial fluids were markedly higher in RA patients than in osteoarthritis (OA) patients. Synovial tissue cells from RA patients more strongly expressed mRNAs for CXCR3 ligands and spontaneously secreted larger amounts of these chemokine proteins than the cells from OA patients. The mRNA expression of all CXCR3 ligands was induced in synovial fibroblasts from RA patients after stimulation with interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), or interleukin-1 beta (IL-1beta). However, synovial fibroblasts significantly secreted CXCL9 and CXCL10 proteins, but not CXCL11 protein, after IFN-gamma stimulation and secreted only CXCL10 protein after TNF-alpha or IL-1beta stimulation. When stimulated with a combination of IFN-gamma and TNF-alpha, these cells were able to secrete large amounts of all three chemokines. These results indicate that synovial fibroblasts may be involved in perpetuating the Th1 immune response by producing the Th1-associated CXCR3 ligands, and the synergistic effect of IFN-gamma and TNF-alpha may be important for their chemokine production in RA joints.
Similar articles
- High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis.
Ruschpler P, Lorenz P, Eichler W, Koczan D, Hänel C, Scholz R, Melzer C, Thiesen HJ, Stiehl P. Ruschpler P, et al. Arthritis Res Ther. 2003;5(5):R241-52. doi: 10.1186/ar783. Epub 2003 Jun 26. Arthritis Res Ther. 2003. PMID: 12932287 Free PMC article. - Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts.
Tsubaki T, Takegawa S, Hanamoto H, Arita N, Kamogawa J, Yamamoto H, Takubo N, Nakata S, Yamada K, Yamamoto S, Yoshie O, Nose M. Tsubaki T, et al. Clin Exp Immunol. 2005 Aug;141(2):363-71. doi: 10.1111/j.1365-2249.2005.02850.x. Clin Exp Immunol. 2005. PMID: 15996201 Free PMC article. - Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Proost P, Verpoest S, Van de Borne K, Schutyser E, Struyf S, Put W, Ronsse I, Grillet B, Opdenakker G, Van Damme J. Proost P, et al. J Leukoc Biol. 2004 May;75(5):777-84. doi: 10.1189/jlb.1003524. Epub 2004 Mar 2. J Leukoc Biol. 2004. PMID: 14996826 - Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Antonelli A, et al. Autoimmun Rev. 2014 Mar;13(3):272-80. doi: 10.1016/j.autrev.2013.10.010. Epub 2013 Nov 2. Autoimmun Rev. 2014. PMID: 24189283 Review. - A review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment.
Dillemans L, De Somer L, Neerinckx B, Proost P. Dillemans L, et al. Cell Mol Life Sci. 2023 Mar 2;80(3):78. doi: 10.1007/s00018-023-04715-w. Cell Mol Life Sci. 2023. PMID: 36862204 Free PMC article. Review.
Cited by
- Regulation of cytokine and chemokine expression by histone lysine methyltransferase MLL1 in rheumatoid arthritis synovial fibroblasts.
Okamoto K, Araki Y, Aizaki Y, Tanaka S, Kadono Y, Mimura T. Okamoto K, et al. Sci Rep. 2024 May 9;14(1):10610. doi: 10.1038/s41598-024-60860-7. Sci Rep. 2024. PMID: 38719857 Free PMC article. - Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity.
Dillemans L, Yu K, De Zutter A, Noppen S, Gouwy M, Berghmans N, Verhallen L, De Bondt M, Vanbrabant L, Brusselmans S, Martens E, Schols D, Verschueren P, Rosenkilde MM, Marques PE, Struyf S, Proost P. Dillemans L, et al. Cell Commun Signal. 2024 Feb 2;22(1):94. doi: 10.1186/s12964-023-01453-1. Cell Commun Signal. 2024. PMID: 38308278 Free PMC article. - Autoreactive B cells in rheumatoid arthritis include mainly activated CXCR3+ memory B cells and plasmablasts.
Reijm S, Kwekkeboom JC, Blomberg NJ, Suurmond J, van der Woude D, Toes RE, Scherer HU. Reijm S, et al. JCI Insight. 2023 Oct 23;8(20):e172006. doi: 10.1172/jci.insight.172006. JCI Insight. 2023. PMID: 37725442 Free PMC article. - Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response.
Filippini F, Giacomelli M, Bazzani C, Fredi M, Semeraro P, Tomasi C, Franceschini F, Caruso A, Cavazzana I, Giagulli C. Filippini F, et al. BMC Med. 2023 Jun 14;21(1):210. doi: 10.1186/s12916-023-02868-w. BMC Med. 2023. PMID: 37316832 Free PMC article. - Fibroblast heterogeneity: Keystone of tissue homeostasis and pathology in inflammation and ageing.
Gauthier V, Kyriazi M, Nefla M, Pucino V, Raza K, Buckley CD, Alsaleh G. Gauthier V, et al. Front Immunol. 2023 Feb 28;14:1137659. doi: 10.3389/fimmu.2023.1137659. eCollection 2023. Front Immunol. 2023. PMID: 36926329 Free PMC article. Review.
References
- Nature. 1985 Jun 20-26;315(6021):672-6 - PubMed
- J Clin Invest. 2001 Nov;108(9):1331-9 - PubMed
- J Immunol. 1998 Dec 1;161(11):6413-20 - PubMed
- Arthritis Rheum. 1997 Jun;40(6):1096-105 - PubMed
- J Immunol. 2002 Jun 15;168(12):6420-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials